Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
Clinical trial NCT06032923 · RECRUITING
Trial details
- NCT number
- NCT06032923
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-13
- Primary completion
- 2028-08-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.